Akums Drugs and Pharmaceuticals is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas. As one of the leading CDMOs in India, the company owns the intellectual property for the manufacturing processes of several of its formulations, and its core business is focused on providing end-to-end product development and manufacturing solutions to its clients.

Akums Drugs & Pharma major competitors are FDC, Aarti Pharmalabs, Marksans Pharma, Strides Pharma Scien, Shilpa Medicare, Supriya Lifescience, Innova Captab.
Market Cap of Akums Drugs & Pharma is ₹7,346 Crs.
While the median market cap of its peers are ₹7,611 Crs.

Akums Drugs & Pharma seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.